A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations

ConclusionsMUDMs would improve on current decision support regarding cost-effectiveness information. Given feasibility challenges, this would be most relevant for diseases with multiple treatments, large burden of disease and requiring more complex models. The current overview offers policy makers a starting point to organize the development, use, and maintenance of MUDMs and to support choices concerning  which diseases and policy decisions they will be helpful for.
Source: PharmacoEconomics - Category: Health Management Source Type: research